{
    "eid": "2-s2.0-84945472937",
    "title": "Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): A randomised, multicentre, placebo-controlled trial",
    "cover-date": "2015-10-24",
    "subject-areas": [
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [],
    "authors": [
        "John D. Grainger"
    ],
    "citedby-count": 179,
    "ref-count": 32,
    "ref-list": [
        "Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance",
        "Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP",
        "Chronic idiopathic thrombocytopenic purpura: Incidence, treatment, and outcome",
        "Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden",
        "Immune thrombocytopenic purpura in childhood in Norway: A prospective, population-based registration",
        "Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group",
        "Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology",
        "Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group (ICIS)",
        "The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia",
        "International consensus report on the investigation and management of primary immune thrombocytopenia",
        "Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura",
        "Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura",
        "The long-term impact of rituximab for childhood immune thrombocytopenia",
        "Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia",
        "Severe chronic refractory immune thrombocytopenic purpura during childhood: A survey of physician management",
        "Splenectomy as a curative treatment for immune thrombocytopenia: A retrospective analysis of 233 patients with a minimum follow up of 10 years",
        "Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy",
        "Preclinical activity of eltrombopag (sb-497115), an oral, nonpeptide thrombopoietin receptor agonist",
        "Haematologica",
        "Eltrombopag for management of chronic immune thrombocytopenia (RAISE): A 6-month, randomised, phase 3 study",
        "Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL\u2122 4.0 Generic Core Scales: A study on behalf of the pays de Loire pediatric hematology network",
        "Quality of life in immune thrombocytopenia following treatment",
        "Risk of infection and death among post-splenectomy patients",
        "Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia",
        "Long-term risks after splenectomy among 8,149 cancer-free American veterans: A cohort study with up to 27 years follow-up",
        "A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia",
        "Rituximab for children with immune thrombocytopenia: A systematic review",
        "Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura",
        "Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: Results of the long-term, open-label EXTEND study",
        "Blood",
        "A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia",
        "Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Philadelphia",
            "affilname": "GlaxoSmithKline, USA",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Ramathibodi Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Siriraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Berlin",
            "affilname": "Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Manchester",
            "affilname": "Royal Manchester Children's Hospital",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Salt Lake City",
            "affilname": "Primary Children's Medical Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Buenos Aires",
            "affilname": "Hospital de Ninos Ricardo Gutierrez",
            "affiliation-country": "Argentina"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Khon Kaen University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pavia",
            "affilname": "Universit\u00e0 degli Studi di Pavia",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Olomouc",
            "affilname": "Fakultn\u00ed Nemocnice Olomouc",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "New York",
            "affilname": "Weill Cornell Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hatyai",
            "affilname": "Prince of Songkla University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Turin",
            "affilname": "Ospedale Infantile Regina Margherita",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Manchester",
            "affilname": "The University of Manchester",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Moscow",
            "affilname": "Izmaylovskaya Children's City Clinical Hospital",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Krasnodar",
            "affilname": "GUZ Regional Children's Clinical Hospital",
            "affiliation-country": "Russian Federation"
        }
    ],
    "funding": [
        "Amgen",
        "Bristol-Myers Squibb",
        "GlaxoSmithKline",
        "Novartis",
        "Baxter International",
        "Novartis Pharmaceuticals Corporation",
        "CSL Behring",
        "Shionogi"
    ]
}